|
OMIM |
Link |
Information gain |
01 |
|
mucopolysaccharidosis type vii
|
[NCBI]
|
0.00465405
|
|
|
GUSB
|
[NCBI]
|
0.00357799
|
|
|
GPS
|
[NCBI]
|
0.00285126
|
|
|
acroosteolysis with osteoporosis and changes in skull and mandible
|
[NCBI]
|
0.00192174
|
|
|
NAD
|
[NCBI]
|
0.00162298
|
|
|
KL
|
[NCBI]
|
0.000856647
|
|
|
HPSE
|
[NCBI]
|
0.000623571
|
|
|
egasyn
|
[NCBI]
|
0.000263619
|
|
|
CHS
|
[NCBI]
|
0.000205058
|
|
|
mucolipidosis ii
|
[NCBI]
|
0.000203748
|
|
|
mucolipidosis iiia
|
[NCBI]
|
0.000167187
|
|
|
acid phosphatase deficiency
|
[NCBI]
|
0.000153402
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
0.000127168
|
|
|
fucosidase regulator
|
[NCBI]
|
0.000121838
|
|
|
MPO
|
[NCBI]
|
0.000106867
|
|
|
CRS1
|
[NCBI]
|
9.64937e-05
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
9.64937e-05
|
|
|
FGF23
|
[NCBI]
|
9.14646e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
8.49038e-05
|
|
|
M6PR
|
[NCBI]
|
8.40756e-05
|
|
|
aspirin resistance
|
[NCBI]
|
7.52615e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
7.16596e-05
|
|
|
gilbert syndrome
|
[NCBI]
|
6.34393e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
6.12679e-05
|
|
|
HFTC
|
[NCBI]
|
5.92946e-05
|
|
|
EGR1
|
[NCBI]
|
5.16176e-05
|
|
|
SDC2
|
[NCBI]
|
4.81969e-05
|
|
|
hurler syndrome
|
[NCBI]
|
4.68205e-05
|
|
|
PTH
|
[NCBI]
|
4.44708e-05
|
|
|
NPC1
|
[NCBI]
|
3.80568e-05
|
|
|
MAN2B1
|
[NCBI]
|
3.78269e-05
|
|
|
S5
|
[NCBI]
|
2.91144e-05
|
|
|
S6
|
[NCBI]
|
2.91144e-05
|
|
|
GBA3
|
[NCBI]
|
2.91144e-05
|
|
|
TNF
|
[NCBI]
|
2.72484e-05
|
|
|
KLB
|
[NCBI]
|
2.63182e-05
|
|
|
CHK
|
[NCBI]
|
2.63182e-05
|
|
|
DFSP
|
[NCBI]
|
2.61909e-05
|
|
|
SLE
|
[NCBI]
|
2.51463e-05
|
|
|
VEGFC
|
[NCBI]
|
2.45045e-05
|
|
|
PHKG1
|
[NCBI]
|
2.45045e-05
|
|
|
MRC1
|
[NCBI]
|
2.31572e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.22346e-05
|
|
|
ENO2
|
[NCBI]
|
2.20848e-05
|
|
|
RFWD2
|
[NCBI]
|
2.20848e-05
|
|
|
HRG
|
[NCBI]
|
2.16782e-05
|
|
|
MDH2
|
[NCBI]
|
2.1194e-05
|
|
|
RABGGTA
|
[NCBI]
|
2.1194e-05
|
|
|
TRPV5
|
[NCBI]
|
2.1194e-05
|
|
|
PSPH
|
[NCBI]
|
2.04322e-05
|
|
|
RPL19
|
[NCBI]
|
1.97669e-05
|
|
|
WNT3A
|
[NCBI]
|
1.81643e-05
|
|
|
COL15A1
|
[NCBI]
|
1.81643e-05
|
|
|
ADAM10
|
[NCBI]
|
1.595e-05
|
|
|
NEU1
|
[NCBI]
|
1.512e-05
|
|
|
GLO1
|
[NCBI]
|
1.378e-05
|
|
|
IGF2R
|
[NCBI]
|
1.30505e-05
|
|
|
FPRL1
|
[NCBI]
|
1.30505e-05
|
|
|
MVK
|
[NCBI]
|
1.30505e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.12249e-05
|
|
|
HEXB
|
[NCBI]
|
1.05679e-05
|
|
|
ADAM17
|
[NCBI]
|
1.02703e-05
|
|
|
DSTN
|
[NCBI]
|
1.02703e-05
|
|
|
IGF1
|
[NCBI]
|
9.23791e-06
|
|
|
GPI
|
[NCBI]
|
8.91489e-06
|
|
|
BMP2
|
[NCBI]
|
8.2676e-06
|
|
|
B2M
|
[NCBI]
|
8.20564e-06
|
|
|
CCL2
|
[NCBI]
|
8.14453e-06
|
|
|
IDUA
|
[NCBI]
|
8.02477e-06
|
|
|
STC1
|
[NCBI]
|
7.57579e-06
|
|
|
GAPDH
|
[NCBI]
|
7.12244e-06
|
|
|
LMNA
|
[NCBI]
|
6.97897e-06
|
|
|
RA
|
[NCBI]
|
6.72573e-06
|
|
|
LBP
|
[NCBI]
|
6.53877e-06
|
|
|
FGFR1
|
[NCBI]
|
5.7447e-06
|
|
|
TBP
|
[NCBI]
|
5.41619e-06
|
|
|
PF4
|
[NCBI]
|
5.00206e-06
|
|
|
AVP
|
[NCBI]
|
4.99441e-06
|
|
|
AGER
|
[NCBI]
|
4.52479e-06
|
|
|
ACP5
|
[NCBI]
|
4.43126e-06
|
|
|
MBP
|
[NCBI]
|
4.09466e-06
|
|
|
APOE
|
[NCBI]
|
4.0871e-06
|
|
|
BCR
|
[NCBI]
|
3.91592e-06
|
|
|
SPINK1
|
[NCBI]
|
3.87496e-06
|
|
|
PCNA
|
[NCBI]
|
3.59777e-06
|
|
|
G6PD
|
[NCBI]
|
3.41132e-06
|
|
|
EPO
|
[NCBI]
|
2.97789e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
2.31574e-06
|
|
|
NGFB
|
[NCBI]
|
1.59042e-06
|
|
|
CF
|
[NCBI]
|
1.56892e-06
|
|
|
F3
|
[NCBI]
|
1.5496e-06
|
|
|
ACE
|
[NCBI]
|
8.04251e-07
|
|
|
HGF
|
[NCBI]
|
7.70063e-07
|
|
|
FGF7
|
[NCBI]
|
7.24982e-07
|
|
|
VDR
|
[NCBI]
|
6.34644e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
5.53112e-07
|
|
|
ACHE
|
[NCBI]
|
4.31141e-07
|
|
|
PTK2
|
[NCBI]
|
3.28784e-07
|
|
|
CAT
|
[NCBI]
|
3.15586e-07
|
|
|
MUC1
|
[NCBI]
|
2.44642e-07
|
|
|
LPL
|
[NCBI]
|
2.09252e-07
|
|
|
CHAT
|
[NCBI]
|
2.01646e-07
|
|
|
VEGF
|
[NCBI]
|
3.90166e-08
|
|
|
PPARA
|
[NCBI]
|
3.88816e-08
|
|
|
CEACAM5
|
[NCBI]
|
3.18234e-08
|
|